Ferguson Sarah E, Brotto Lori A, Kwon Janice, Samouelian Vanessa, Ferron Gwenael, Maulard Amandine, Kroon Cor de, Driel Willemien Van, Tidy John, Williamson Karin, Mahner Sven, Kommoss Stefan, Goffin Frederic, Tamussino Karl, Eyjolfsdottir Brynhildur, Kim Jae-Weon, Gleeson Noreen, Tu Dongsheng, Shepherd Lois, Plante Marie
Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
University of British Columbia, Vancouver, British Columbia, Canada.
J Clin Oncol. 2025 Jan 10;43(2):167-179. doi: 10.1200/JCO.24.00440. Epub 2024 Oct 1.
Simple hysterectomy and pelvic node assessment (SHAPE) is a phase III randomized trial (ClinicalTrials.gov identifier: NCT01658930) reporting noninferiority of simple compared with radical hysterectomy for oncologic outcomes in low-risk cervical cancer. This study presents secondary outcomes of sexual health and quality of life (QOL) of the SHAPE trial.
Participants were randomly assigned to receive either radical or simple hysterectomy. Sexual health was assessed up to 36 months postoperatively using the Female Sexual Function Index (FSFI) and Female Sexual Distress Scale-Revised and QOL using European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 and Cervical Cancer-Specific Module (QLQ-CX24) questionnaires.
Among participants with at least one QOL measure, clinical and pathologic characteristics were balanced and with no differences in preoperative baseline scores for sexual health or QOL between groups. FSFI total score met the cutoff for dysfunction up to 6 months ( = .02) in the radical hysterectomy group. Group differences favored simple hysterectomy for FSFI subscales: desire and arousal at 3 months ( ≤ .001) and pain and lubrication up to 12 months ( ≤ .018). Both groups met the cutoff for sexual distress but was higher in radical hysterectomy at 3 months ( = .018). For QLQ-CX24, symptom experience was significantly better up to 24 months ( = .031) and body image better at 3, 24, and 36 months ( ≤ .01) for simple hysterectomy. Sexual-vaginal functioning was significantly better up to 24 months ( ≤ .022) and more sexual activity up to 36 months ( = .024) in the simple hysterectomy arm. Global health status was significantly higher at 36 months for simple hysterectomy ( = .025).
Simple hysterectomy was associated with lower rates of sexual dysfunction than radical hysterectomy, with a lower proportion of women having sustained sexual-vaginal dysfunction. These results further support the benefit of surgical de-escalation for low-risk cervical cancer.
单纯子宫切除术和盆腔淋巴结评估(SHAPE)是一项III期随机试验(ClinicalTrials.gov标识符:NCT01658930),报告了在低风险宫颈癌的肿瘤学结局方面,单纯子宫切除术与根治性子宫切除术相比具有非劣效性。本研究展示了SHAPE试验的性健康和生活质量(QOL)的次要结局。
参与者被随机分配接受根治性或单纯子宫切除术。术后长达36个月使用女性性功能指数(FSFI)和修订后的女性性困扰量表评估性健康,并使用欧洲癌症研究与治疗组织生活质量问卷核心30和宫颈癌特异性模块(QLQ-CX24)问卷评估生活质量。
在至少有一项生活质量测量的参与者中,临床和病理特征均衡,两组之间性健康或生活质量的术前基线评分无差异。根治性子宫切除术组中,FSFI总分在长达6个月时达到功能障碍临界值( = 0.02)。对于FSFI子量表,组间差异有利于单纯子宫切除术:3个月时的性欲和性唤起( ≤ 0.001)以及长达12个月时的疼痛和润滑( ≤ 0.018)。两组均达到性困扰临界值,但根治性子宫切除术组在3个月时更高( = 0.018)。对于QLQ-CX24,单纯子宫切除术在长达24个月时症状体验明显更好( = 0.031),在3、24和36个月时身体形象更好( ≤ 0.01)。单纯子宫切除术组在长达24个月时性 - 阴道功能明显更好( ≤ 0.022),在长达36个月时性活动更多( = 0.024)。单纯子宫切除术在36个月时总体健康状况明显更高( = 0.025)。
与根治性子宫切除术相比,单纯子宫切除术的性功能障碍发生率较低,持续性性 - 阴道功能障碍的女性比例较低。这些结果进一步支持了低风险宫颈癌手术降阶梯的益处。